M
Matthew P. Fox
Researcher at Boston University
Publications - 337
Citations - 14658
Matthew P. Fox is an academic researcher from Boston University. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 57, co-authored 300 publications receiving 12378 citations. Previous affiliations of Matthew P. Fox include University of Minnesota & University of the Witwatersrand.
Papers
More filters
Journal Article
AIDS is your business.
Sydney Rosen,Jonathon L Simon,Jeffrey R. Vincent,William B. MacLeod,Matthew P. Fox,Donald M. Thea +5 more
TL;DR: All six companies would have earned positive returns on their investments if they had provided employees with free treatment for HIV/AIDS in the form of highly active antiretroviral therapy (HAART), according to the mathematical model the authors used.
Journal ArticleDOI
Mortality in Patients with HIV-1 Infection Starting Antiretroviral Therapy in South Africa, Europe, or North America: A Collaborative Analysis of Prospective Studies
Andrew Boulle,Michael Schomaker,Margaret T May,Robert S. Hogg,Bryan E. Shepherd,Susana Monge,Olivia Keiser,Fiona C Lampe,Janet Giddy,James Ndirangu,Daniela Garone,Matthew P. Fox,Suzanne M Ingle,Peter Reiss,François Dabis,Dominique Costagliola,Antonella Castagna,Kathrin Ehren,Colin Campbell,M. John Gill,Michael S. Saag,Amy C. Justice,Jodie L. Guest,Heidi M. Crane,Matthias Egger,Jonathan A C Sterne +25 more
TL;DR: Analyzing survival in HIV treatment cohorts, Andrew Boulle and colleagues find mortality rates in South Africa comparable to or better than those in North America by 4 years after starting antiretroviral therapy.
Journal ArticleDOI
A meta-analysis assessing all-cause mortality in HIV-exposed uninfected compared with HIV-unexposed uninfected infants and children.
Alana T. Brennan,Rachael Bonawitz,Christopher J. Gill,Donald M. Thea,Mary Kleinman,Johanna Useem,Lindsey Garrison,Rachel Ceccarelli,Chinenye Udokwu,Lawrence Long,Matthew P. Fox +10 more
TL;DR: A consistent increase risk of mortality for HEU vs. HUU infants and children is shown, suggesting that prenatal antiretroviral therapy, and healthier mothers, does not fully eliminate this increased risk in mortality.
Journal ArticleDOI
Using vital registration data to update mortality among patients lost to follow‐up from ART programmes: evidence from the Themba Lethu Clinic, South Africa
TL;DR: To estimate the rates of mortality in patients lost to follow‐up (LTFU) from a large urban public sector HIV clinic in South Africa, data are collected on patients with confirmed or suspected HIV infection, followed by a follow-up period of 12 months.
Journal ArticleDOI
Loss to follow-up before and after delivery among women testing HIV positive during pregnancy in Johannesburg, South Africa
Kate Clouse,Kate Clouse,Audrey Pettifor,Kate Shearer,Mhairi Maskew,Jean Bassett,Bruce A. Larson,Bruce A. Larson,Annelies Van Rie,Ian Sanne,Matthew P. Fox,Matthew P. Fox +11 more
TL;DR: HIV‐positive pregnant women are at heightened risk of becoming lost to follow‐up (LTFU) from HIV care and this work examined LTFU before and after delivery among pregnant women newly diagnosed with HIV.